The Second Affiliated Hospital of Fujian Medical University — Quanzhou, Fujian

Public research footprint of The Second Affiliated Hospital of Fujian Medical University, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma · HR+/HER2- Breast Cancer · HER2-positive Breast Cancer · Hepatocellular Carcinoma Non-resectable

Recently updated registry entries

NCT06872892 — The AIRTIVITY™ Study: A Study to Find Out Whether BI 1291583 Helps People With… (Recruiting)
NCT06456346 — Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007) (Active Not Recruiting)
NCT06079879 — A Study of Bomedemstat (IMG-7289/MK-3543) Compared to Best Available Therapy (BAT) in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at The Second Affiliated Hospital of Fujian Medical University?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 06, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.